get rid of all the incompetent executives once and for all...the company is still in a crisis and this idiot is busy doing drug. what a piece of #$%$.
give them another qtr or so...once they get more data, they will be able to provide better guidance...
vrtx didn't provide guidance on orkambi until last week, when the drug was approved last year and a few qtr's sales in the books.
they digested what management says and we get better ideas where things stand now and going forward...they like what they read and saw...they see the stock being cheap down here...110 by end of year is what wall street expects...vrtx owns the cf market.
1.0-1.1 billion for 2016....vs exp. 1.2-1.3b
a bit short. but i think ok for now. very much priced in and the guidance is actually not as bad as some feared. great to finally get that number from the company.
not gonna be 20. management wouldn't entertain this kind of offer and certainly won't need to hire a firm to halp with the trouble for 20/share
i expect 35 plus...